We offer innovative NGS-based solutions for the quality control of biologics and the diagnosis of infectious diseases to improve the quality of life of patients by accelerating commercial availability of biologics and assisting with the rapid diagnosis of infectious diseases
About Us


About Us
We offer innovative NGS-based solutions for the quality control of biologics and the diagnosis of infectious diseases to improve the quality of life of patients by accelerating commercial availability of biologics and assisting with the rapid diagnosis of infectious diseases
WHAT WE DO
PathoQuest, a spin-out of Institut Pasteur Paris, is a genomic expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.
The NGS-based technology the company developed is used for:
- The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP level
- The diagnosis of infections (including sepsis) based on blood samples
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
OUR MISSION & VISION

PathoQuest develops proprietary metagenomic-based tests and software tools that are designed to improve the detection and identification of pathogens, to foster the development of precision medicine in infectious diseases, and enable the safe and high-quality production of biologics.

- To become a worldwide leader in the quality control for biologics and bioproduction samples, and to accelerate the time to market for innovative drugs
- To make iDTECT® the reference in clinical routine for the diagnosis of severe infectious diseases
| HOW WE DO IT
Projects
Customers
Employees
Sites
| OUR PEOPLE
Management Team
PathoQuest’s management team has significant experience and expertise in in-vitro diagnostics, for the development, validation, and commercialization of metagenomic solutions for the identification of pathogens.
Board of Directors
PathoQuest is led by a board of directors who are seasoned leaders in their respective fields of business. Together, the members of the board of directors help to develop policies and strategies which are implemented by PathoQuest’s executive team.
Scientific Advisors
PathoQuest is guided by a Scientific Advisory Board of recognized experts in the fields of infectious diseases, microbiology, and molecular diagnostics. They assist PathoQuest in its R&D efforts and implementation of the clinical development strategy.
OUR HISTORY
Let’s Start Something New
Welcome to PathoQuest!